NFKB1 and neoplasm: At the same time, the transcription factor NF-κB plays a dual role in tumor immunity progresses: although it initially promotes anti-tumor T cell response during the elimination phase, long-term tumor antigen stimulation overstimulates NF-κB, driving PD-L1 expression and exacerbating T cell exhaustion (23, 24).